Pharmaceutical Expansion Will Unlock Global Healthcare Opportunities Despite Risks

Published
23 Feb 25
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
JP¥9,154.55
13.4% undervalued intrinsic discount
14 Aug
JP¥7,924.00
Loading
1Y
-2.8%
7D
1.4%

Author's Valuation

JP¥9.2k

13.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 0.83%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 3.01%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 1.31%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 4.18%

AnalystConsensusTarget has increased revenue growth from 2.3% to 2.8%.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 2.30%

AnalystConsensusTarget has increased revenue growth from 2.1% to 2.3%.

Shared on12 Mar 25
Fair value Increased 0.28%